Latest News

Date Title Topic
27 Oct 2015 FDA Approves Trabectedin for Certain Types of Advanced Soft Tissue Sarcoma Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Oct 2015 EMA Adopts a Positive Opinion Recommending to Extend Therapeutic Indications for Crizotinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Oct 2015 EMA Recommends Approval of First Oncolytic Immunotherapy Medicine Melanoma - Cancer Immunology and Immunotherapy
23 Oct 2015 MAP 2015 Press Release: Genomic Alterations Could Lead to a Brave New World for Cancer Treatment
21 Oct 2015 Drug Repurposing in Oncology Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
20 Oct 2015 BRAF & NRAS in Melanoma Factsheets
14 Oct 2015 FDA Approves Expanded Indication for Medical Device to Treat Glioblastoma Multiforme Central nervous system malignancies
13 Oct 2015 FDA Expands Approved Use of Nivolumab in Advanced Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
12 Oct 2015 The Nobel Prize in Chemistry 2015 for Mechanistic Studies of DNA Repair Basic science
09 Oct 2015 European Medicines Agency Recommends Granting Marketing Authorisation for Cinacalcet Mylan Endocrine cancers
08 Oct 2015 European Medicines Agency Adopts a New Indication for Azacitidine Cancer in Special Situations - Haematologic malignancies - Anticancer agents & Biologic therapy
07 Oct 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Carfilzomib Haematologic malignancies - Anticancer agents & Biologic therapy
07 Oct 2015 EMA Recommends Granting a Marketing Authorisation for Blinatumomab Haematologic malignancies - Cancer Immunology and Immunotherapy
06 Oct 2015 FDA Approves Pembrolizumab for Advanced Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
05 Oct 2015 FDA Approves New Oral Medication to Treat Patients With Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy